0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vascular Embolization Agent Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2D13682
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Vascular Embolization Agent Market Insights Forecast to 2029
BUY CHAPTERS

Global Vascular Embolization Agent Market Research Report 2025

Code: QYRE-Auto-2D13682
Report
May 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vascular Embolization Agent Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Vascular Embolization Agent Market

Vascular Embolization Agent Market

The global market for Vascular Embolization Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vascular Embolization Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Embolization Agent.
The Vascular Embolization Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vascular Embolization Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vascular Embolization Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vascular Embolization Agent Market Report

Report Metric Details
Report Name Vascular Embolization Agent Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Temporary
  • Permanent
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vascular Embolization Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vascular Embolization Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vascular Embolization Agent Market report?

Ans: The main players in the Vascular Embolization Agent Market are Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology

What are the Application segmentation covered in the Vascular Embolization Agent Market report?

Ans: The Applications covered in the Vascular Embolization Agent Market report are Hospital, Ambulatory Surgery Center

What are the Type segmentation covered in the Vascular Embolization Agent Market report?

Ans: The Types covered in the Vascular Embolization Agent Market report are Temporary, Permanent

Recommended Reports

Vascular Devices

Embolization Markets

Vascular Imaging & Monitoring

1 Vascular Embolization Agent Market Overview
1.1 Product Definition
1.2 Vascular Embolization Agent by Type
1.2.1 Global Vascular Embolization Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Temporary
1.2.3 Permanent
1.3 Vascular Embolization Agent by Application
1.3.1 Global Vascular Embolization Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Global Vascular Embolization Agent Market Size Estimates and Forecasts
1.4.1 Global Vascular Embolization Agent Revenue 2020-2031
1.4.2 Global Vascular Embolization Agent Sales 2020-2031
1.4.3 Global Vascular Embolization Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vascular Embolization Agent Market Competition by Manufacturers
2.1 Global Vascular Embolization Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vascular Embolization Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vascular Embolization Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vascular Embolization Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vascular Embolization Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vascular Embolization Agent, Product Type & Application
2.7 Global Key Manufacturers of Vascular Embolization Agent, Date of Enter into This Industry
2.8 Global Vascular Embolization Agent Market Competitive Situation and Trends
2.8.1 Global Vascular Embolization Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vascular Embolization Agent Players Market Share by Revenue
2.8.3 Global Vascular Embolization Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vascular Embolization Agent Market Scenario by Region
3.1 Global Vascular Embolization Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vascular Embolization Agent Sales by Region: 2020-2031
3.2.1 Global Vascular Embolization Agent Sales by Region: 2020-2025
3.2.2 Global Vascular Embolization Agent Sales by Region: 2026-2031
3.3 Global Vascular Embolization Agent Revenue by Region: 2020-2031
3.3.1 Global Vascular Embolization Agent Revenue by Region: 2020-2025
3.3.2 Global Vascular Embolization Agent Revenue by Region: 2026-2031
3.4 North America Vascular Embolization Agent Market Facts & Figures by Country
3.4.1 North America Vascular Embolization Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vascular Embolization Agent Sales by Country (2020-2031)
3.4.3 North America Vascular Embolization Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vascular Embolization Agent Market Facts & Figures by Country
3.5.1 Europe Vascular Embolization Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vascular Embolization Agent Sales by Country (2020-2031)
3.5.3 Europe Vascular Embolization Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vascular Embolization Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Vascular Embolization Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vascular Embolization Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Vascular Embolization Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vascular Embolization Agent Market Facts & Figures by Country
3.7.1 Latin America Vascular Embolization Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vascular Embolization Agent Sales by Country (2020-2031)
3.7.3 Latin America Vascular Embolization Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vascular Embolization Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Vascular Embolization Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vascular Embolization Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vascular Embolization Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vascular Embolization Agent Sales by Type (2020-2031)
4.1.1 Global Vascular Embolization Agent Sales by Type (2020-2025)
4.1.2 Global Vascular Embolization Agent Sales by Type (2026-2031)
4.1.3 Global Vascular Embolization Agent Sales Market Share by Type (2020-2031)
4.2 Global Vascular Embolization Agent Revenue by Type (2020-2031)
4.2.1 Global Vascular Embolization Agent Revenue by Type (2020-2025)
4.2.2 Global Vascular Embolization Agent Revenue by Type (2026-2031)
4.2.3 Global Vascular Embolization Agent Revenue Market Share by Type (2020-2031)
4.3 Global Vascular Embolization Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vascular Embolization Agent Sales by Application (2020-2031)
5.1.1 Global Vascular Embolization Agent Sales by Application (2020-2025)
5.1.2 Global Vascular Embolization Agent Sales by Application (2026-2031)
5.1.3 Global Vascular Embolization Agent Sales Market Share by Application (2020-2031)
5.2 Global Vascular Embolization Agent Revenue by Application (2020-2031)
5.2.1 Global Vascular Embolization Agent Revenue by Application (2020-2025)
5.2.2 Global Vascular Embolization Agent Revenue by Application (2026-2031)
5.2.3 Global Vascular Embolization Agent Revenue Market Share by Application (2020-2031)
5.3 Global Vascular Embolization Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Vascular Embolization Agent Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Company Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Corporation Vascular Embolization Agent Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Cook Medical LLC
6.3.1 Cook Medical LLC Company Information
6.3.2 Cook Medical LLC Description and Business Overview
6.3.3 Cook Medical LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cook Medical LLC Vascular Embolization Agent Product Portfolio
6.3.5 Cook Medical LLC Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Vascular Embolization Agent Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Vascular Embolization Agent Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Acandis GmbH
6.6.1 Acandis GmbH Company Information
6.6.2 Acandis GmbH Description and Business Overview
6.6.3 Acandis GmbH Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Acandis GmbH Vascular Embolization Agent Product Portfolio
6.6.5 Acandis GmbH Recent Developments/Updates
6.7 SSEM Mthembu Medical (Pty) Ltd
6.7.1 SSEM Mthembu Medical (Pty) Ltd Company Information
6.7.2 SSEM Mthembu Medical (Pty) Ltd Description and Business Overview
6.7.3 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product Portfolio
6.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
6.8 Balt USA LLC
6.8.1 Balt USA LLC Company Information
6.8.2 Balt USA LLC Description and Business Overview
6.8.3 Balt USA LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Balt USA LLC Vascular Embolization Agent Product Portfolio
6.8.5 Balt USA LLC Recent Developments/Updates
6.9 Stryker
6.9.1 Stryker Company Information
6.9.2 Stryker Description and Business Overview
6.9.3 Stryker Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Stryker Vascular Embolization Agent Product Portfolio
6.9.5 Stryker Recent Developments/Updates
6.10 Guerbet LLC
6.10.1 Guerbet LLC Company Information
6.10.2 Guerbet LLC Description and Business Overview
6.10.3 Guerbet LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Guerbet LLC Vascular Embolization Agent Product Portfolio
6.10.5 Guerbet LLC Recent Developments/Updates
6.11 Terumo Corporation
6.11.1 Terumo Corporation Company Information
6.11.2 Terumo Corporation Description and Business Overview
6.11.3 Terumo Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Terumo Corporation Vascular Embolization Agent Product Portfolio
6.11.5 Terumo Corporation Recent Developments/Updates
6.12 Penumbra
6.12.1 Penumbra Company Information
6.12.2 Penumbra Description and Business Overview
6.12.3 Penumbra Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Penumbra Vascular Embolization Agent Product Portfolio
6.12.5 Penumbra Recent Developments/Updates
6.13 Grandpharma (Sirtex)
6.13.1 Grandpharma (Sirtex) Company Information
6.13.2 Grandpharma (Sirtex) Description and Business Overview
6.13.3 Grandpharma (Sirtex) Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Grandpharma (Sirtex) Vascular Embolization Agent Product Portfolio
6.13.5 Grandpharma (Sirtex) Recent Developments/Updates
6.14 Merit Medical
6.14.1 Merit Medical Company Information
6.14.2 Merit Medical Description and Business Overview
6.14.3 Merit Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merit Medical Vascular Embolization Agent Product Portfolio
6.14.5 Merit Medical Recent Developments/Updates
6.15 Siemens Healthineers (Varian)
6.15.1 Siemens Healthineers (Varian) Company Information
6.15.2 Siemens Healthineers (Varian) Description and Business Overview
6.15.3 Siemens Healthineers (Varian) Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Siemens Healthineers (Varian) Vascular Embolization Agent Product Portfolio
6.15.5 Siemens Healthineers (Varian) Recent Developments/Updates
6.16 Jiangsu Hengrui Medicine
6.16.1 Jiangsu Hengrui Medicine Company Information
6.16.2 Jiangsu Hengrui Medicine Description and Business Overview
6.16.3 Jiangsu Hengrui Medicine Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jiangsu Hengrui Medicine Vascular Embolization Agent Product Portfolio
6.16.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.17 Kaneka
6.17.1 Kaneka Company Information
6.17.2 Kaneka Description and Business Overview
6.17.3 Kaneka Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Kaneka Vascular Embolization Agent Product Portfolio
6.17.5 Kaneka Recent Developments/Updates
6.18 Meril Life Sciences
6.18.1 Meril Life Sciences Company Information
6.18.2 Meril Life Sciences Description and Business Overview
6.18.3 Meril Life Sciences Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Meril Life Sciences Vascular Embolization Agent Product Portfolio
6.18.5 Meril Life Sciences Recent Developments/Updates
6.19 Peijia Medical
6.19.1 Peijia Medical Company Information
6.19.2 Peijia Medical Description and Business Overview
6.19.3 Peijia Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Peijia Medical Vascular Embolization Agent Product Portfolio
6.19.5 Peijia Medical Recent Developments/Updates
6.20 Wallaby Medical
6.20.1 Wallaby Medical Company Information
6.20.2 Wallaby Medical Description and Business Overview
6.20.3 Wallaby Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Wallaby Medical Vascular Embolization Agent Product Portfolio
6.20.5 Wallaby Medical Recent Developments/Updates
6.21 MicroPort Scientific Corporation
6.21.1 MicroPort Scientific Corporation Company Information
6.21.2 MicroPort Scientific Corporation Description and Business Overview
6.21.3 MicroPort Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.21.4 MicroPort Scientific Corporation Vascular Embolization Agent Product Portfolio
6.21.5 MicroPort Scientific Corporation Recent Developments/Updates
6.22 Weihai Visee Medical Devices
6.22.1 Weihai Visee Medical Devices Company Information
6.22.2 Weihai Visee Medical Devices Description and Business Overview
6.22.3 Weihai Visee Medical Devices Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Weihai Visee Medical Devices Vascular Embolization Agent Product Portfolio
6.22.5 Weihai Visee Medical Devices Recent Developments/Updates
6.23 Beijing Taijieweiye Technology
6.23.1 Beijing Taijieweiye Technology Company Information
6.23.2 Beijing Taijieweiye Technology Description and Business Overview
6.23.3 Beijing Taijieweiye Technology Vascular Embolization Agent Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Beijing Taijieweiye Technology Vascular Embolization Agent Product Portfolio
6.23.5 Beijing Taijieweiye Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vascular Embolization Agent Industry Chain Analysis
7.2 Vascular Embolization Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vascular Embolization Agent Production Mode & Process Analysis
7.4 Vascular Embolization Agent Sales and Marketing
7.4.1 Vascular Embolization Agent Sales Channels
7.4.2 Vascular Embolization Agent Distributors
7.5 Vascular Embolization Agent Customer Analysis
8 Vascular Embolization Agent Market Dynamics
8.1 Vascular Embolization Agent Industry Trends
8.2 Vascular Embolization Agent Market Drivers
8.3 Vascular Embolization Agent Market Challenges
8.4 Vascular Embolization Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vascular Embolization Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vascular Embolization Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vascular Embolization Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vascular Embolization Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vascular Embolization Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vascular Embolization Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vascular Embolization Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vascular Embolization Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vascular Embolization Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vascular Embolization Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vascular Embolization Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Vascular Embolization Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vascular Embolization Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Embolization Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vascular Embolization Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vascular Embolization Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Vascular Embolization Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Vascular Embolization Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Vascular Embolization Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Vascular Embolization Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vascular Embolization Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Vascular Embolization Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vascular Embolization Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Vascular Embolization Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vascular Embolization Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Vascular Embolization Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Vascular Embolization Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vascular Embolization Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vascular Embolization Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vascular Embolization Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Vascular Embolization Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Vascular Embolization Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vascular Embolization Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vascular Embolization Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vascular Embolization Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Vascular Embolization Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Vascular Embolization Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vascular Embolization Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vascular Embolization Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vascular Embolization Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Vascular Embolization Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Vascular Embolization Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vascular Embolization Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vascular Embolization Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vascular Embolization Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Vascular Embolization Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Vascular Embolization Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vascular Embolization Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vascular Embolization Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Vascular Embolization Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Vascular Embolization Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Vascular Embolization Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Vascular Embolization Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vascular Embolization Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vascular Embolization Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Vascular Embolization Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Vascular Embolization Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Vascular Embolization Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Vascular Embolization Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Vascular Embolization Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Vascular Embolization Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Vascular Embolization Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Vascular Embolization Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vascular Embolization Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vascular Embolization Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Vascular Embolization Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Vascular Embolization Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Vascular Embolization Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Vascular Embolization Agent Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Corporation Company Information
 Table 76. Boston Scientific Corporation Description and Business Overview
 Table 77. Boston Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Corporation Vascular Embolization Agent Product
 Table 79. Boston Scientific Corporation Recent Developments/Updates
 Table 80. Cook Medical LLC Company Information
 Table 81. Cook Medical LLC Description and Business Overview
 Table 82. Cook Medical LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Cook Medical LLC Vascular Embolization Agent Product
 Table 84. Cook Medical LLC Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Vascular Embolization Agent Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Medtronic Company Information
 Table 91. Medtronic Description and Business Overview
 Table 92. Medtronic Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Medtronic Vascular Embolization Agent Product
 Table 94. Medtronic Recent Developments/Updates
 Table 95. Acandis GmbH Company Information
 Table 96. Acandis GmbH Description and Business Overview
 Table 97. Acandis GmbH Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Acandis GmbH Vascular Embolization Agent Product
 Table 99. Acandis GmbH Recent Developments/Updates
 Table 100. SSEM Mthembu Medical (Pty) Ltd Company Information
 Table 101. SSEM Mthembu Medical (Pty) Ltd Description and Business Overview
 Table 102. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product
 Table 104. SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
 Table 105. Balt USA LLC Company Information
 Table 106. Balt USA LLC Description and Business Overview
 Table 107. Balt USA LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Balt USA LLC Vascular Embolization Agent Product
 Table 109. Balt USA LLC Recent Developments/Updates
 Table 110. Stryker Company Information
 Table 111. Stryker Description and Business Overview
 Table 112. Stryker Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Stryker Vascular Embolization Agent Product
 Table 114. Stryker Recent Developments/Updates
 Table 115. Guerbet LLC Company Information
 Table 116. Guerbet LLC Description and Business Overview
 Table 117. Guerbet LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Guerbet LLC Vascular Embolization Agent Product
 Table 119. Guerbet LLC Recent Developments/Updates
 Table 120. Terumo Corporation Company Information
 Table 121. Terumo Corporation Description and Business Overview
 Table 122. Terumo Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Terumo Corporation Vascular Embolization Agent Product
 Table 124. Terumo Corporation Recent Developments/Updates
 Table 125. Penumbra Company Information
 Table 126. Penumbra Description and Business Overview
 Table 127. Penumbra Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Penumbra Vascular Embolization Agent Product
 Table 129. Penumbra Recent Developments/Updates
 Table 130. Grandpharma (Sirtex) Company Information
 Table 131. Grandpharma (Sirtex) Description and Business Overview
 Table 132. Grandpharma (Sirtex) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Grandpharma (Sirtex) Vascular Embolization Agent Product
 Table 134. Grandpharma (Sirtex) Recent Developments/Updates
 Table 135. Merit Medical Company Information
 Table 136. Merit Medical Description and Business Overview
 Table 137. Merit Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Merit Medical Vascular Embolization Agent Product
 Table 139. Merit Medical Recent Developments/Updates
 Table 140. Siemens Healthineers (Varian) Company Information
 Table 141. Siemens Healthineers (Varian) Description and Business Overview
 Table 142. Siemens Healthineers (Varian) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Siemens Healthineers (Varian) Vascular Embolization Agent Product
 Table 144. Siemens Healthineers (Varian) Recent Developments/Updates
 Table 145. Jiangsu Hengrui Medicine Company Information
 Table 146. Jiangsu Hengrui Medicine Description and Business Overview
 Table 147. Jiangsu Hengrui Medicine Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Jiangsu Hengrui Medicine Vascular Embolization Agent Product
 Table 149. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 150. Kaneka Company Information
 Table 151. Kaneka Description and Business Overview
 Table 152. Kaneka Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Kaneka Vascular Embolization Agent Product
 Table 154. Kaneka Recent Developments/Updates
 Table 155. Meril Life Sciences Company Information
 Table 156. Meril Life Sciences Description and Business Overview
 Table 157. Meril Life Sciences Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Meril Life Sciences Vascular Embolization Agent Product
 Table 159. Meril Life Sciences Recent Developments/Updates
 Table 160. Peijia Medical Company Information
 Table 161. Peijia Medical Description and Business Overview
 Table 162. Peijia Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Peijia Medical Vascular Embolization Agent Product
 Table 164. Peijia Medical Recent Developments/Updates
 Table 165. Wallaby Medical Company Information
 Table 166. Wallaby Medical Description and Business Overview
 Table 167. Wallaby Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Wallaby Medical Vascular Embolization Agent Product
 Table 169. Wallaby Medical Recent Developments/Updates
 Table 170. MicroPort Scientific Corporation Company Information
 Table 171. MicroPort Scientific Corporation Description and Business Overview
 Table 172. MicroPort Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. MicroPort Scientific Corporation Vascular Embolization Agent Product
 Table 174. MicroPort Scientific Corporation Recent Developments/Updates
 Table 175. Weihai Visee Medical Devices Company Information
 Table 176. Weihai Visee Medical Devices Description and Business Overview
 Table 177. Weihai Visee Medical Devices Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Weihai Visee Medical Devices Vascular Embolization Agent Product
 Table 179. Weihai Visee Medical Devices Recent Developments/Updates
 Table 180. Beijing Taijieweiye Technology Company Information
 Table 181. Beijing Taijieweiye Technology Description and Business Overview
 Table 182. Beijing Taijieweiye Technology Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Beijing Taijieweiye Technology Vascular Embolization Agent Product
 Table 184. Beijing Taijieweiye Technology Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Vascular Embolization Agent Distributors List
 Table 188. Vascular Embolization Agent Customers List
 Table 189. Vascular Embolization Agent Market Trends
 Table 190. Vascular Embolization Agent Market Drivers
 Table 191. Vascular Embolization Agent Market Challenges
 Table 192. Vascular Embolization Agent Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vascular Embolization Agent
 Figure 2. Global Vascular Embolization Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vascular Embolization Agent Market Share by Type: 2024 & 2031
 Figure 4. Temporary Product Picture
 Figure 5. Permanent Product Picture
 Figure 6. Global Vascular Embolization Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Vascular Embolization Agent Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Ambulatory Surgery Center
 Figure 10. Global Vascular Embolization Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Vascular Embolization Agent Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Vascular Embolization Agent Sales (2020-2031) & (K Units)
 Figure 13. Global Vascular Embolization Agent Average Price (US$/Unit) & (2020-2031)
 Figure 14. Vascular Embolization Agent Report Years Considered
 Figure 15. Vascular Embolization Agent Sales Share by Manufacturers in 2024
 Figure 16. Global Vascular Embolization Agent Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Vascular Embolization Agent Players: Market Share by Revenue in Vascular Embolization Agent in 2024
 Figure 18. Vascular Embolization Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Vascular Embolization Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Vascular Embolization Agent Sales Market Share by Country (2020-2031)
 Figure 21. North America Vascular Embolization Agent Revenue Market Share by Country (2020-2031)
 Figure 22. United States Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Vascular Embolization Agent Sales Market Share by Country (2020-2031)
 Figure 25. Europe Vascular Embolization Agent Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Vascular Embolization Agent Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Vascular Embolization Agent Revenue Market Share by Region (2020-2031)
 Figure 33. China Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Vascular Embolization Agent Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Vascular Embolization Agent Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Vascular Embolization Agent Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Vascular Embolization Agent Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Vascular Embolization Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Vascular Embolization Agent by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Vascular Embolization Agent by Type (2020-2031)
 Figure 52. Global Vascular Embolization Agent Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Vascular Embolization Agent by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Vascular Embolization Agent by Application (2020-2031)
 Figure 55. Global Vascular Embolization Agent Price (US$/Unit) by Application (2020-2031)
 Figure 56. Vascular Embolization Agent Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart